SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615774-17-001721
Filing Date
2017-04-17
Accepted
2017-04-17 16:06:06
Documents
73
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K s105817_10k.htm 10-K 1162683
2 EXHIBIT 23.01 s105817_ex23-01.htm EX-23.01 3187
3 EXHIBIT 31.1 s105817_ex31-1.htm EX-31.1 7863
4 EXHIBIT 31.2 s105817_ex31-2.htm EX-31.2 7826
5 EXHIBIT 32.1 s105817_ex32-1.htm EX-32.1 5485
6 EXHIBIT 32.2 s105817_ex32-2.htm EX-32.2 5367
  Complete submission text file 0001615774-17-001721.txt   4619009

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE nspx-20161231.xml EX-101.INS 759621
8 XBRL SCHEMA FILE nspx-20161231.xsd EX-101.SCH 46366
9 XBRL CALCULATION FILE nspx-20161231_cal.xml EX-101.CAL 44650
10 XBRL DEFINITION FILE nspx-20161231_def.xml EX-101.DEF 181535
11 XBRL LABEL FILE nspx-20161231_lab.xml EX-101.LAB 350268
12 XBRL PRESENTATION FILE nspx-20161231_pre.xml EX-101.PRE 282954
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55331 | Film No.: 17764635
SIC: 2834 Pharmaceutical Preparations